Floatz logo

Nefopam

Pain, Postoperative

University Hospital, BordeauxSmall moleculePhase 2/3Dormant
B
58/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
81/ 100

Competitive context

32 Active assets in the Pain, Postoperative cohort.

Asset / SponsorPhaseRating
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Ataturk University
Phase 4BBB
ROPIVACAINE
University of California, Los Angeles
Phase 4BBB
LIDOCAINE
Ataturk University
Phase 4BBB
Epinephrine
University of California, Los Angeles
Phase 4BBB
NEPENTHE
Samsun University
Phase 4BBB

View all 50 →

Same molecule, other indications

Nefopam is also rated in:

chronic pain syndromeDormant
B
Indicative ·
61 / 100
View asset →
HyperalgesiaDormant
B
Indicative ·
61 / 100
View asset →
post-operative pain, non-human animalDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →